Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database
BBA Clinical · 2017-06 · 7 · 147-156
DOI: 10.1016/j.bbacli.2017.04.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift BBA Clinical, 2017-06. Verfasst von Anssi Nurminen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, University of Tampere.
Abstract (Originalsprache)
DNA polymerase gamma (POLG) is the replicative polymerase responsible for maintaining mitochondrial DNA (mtDNA). Disorders related to its functionality are a major cause of mitochondrial disease. The clinical spectrum of POLG syndromes includes Alpers-Huttenlocher syndrome (AHS), childhood myocerebrohepatopathy spectrum (MCHS), myoclonic epilepsy myopathy sensory ataxia (MEMSA), the ataxia neuropathy spectrum (ANS) and progressive external ophthalmoplegia (PEO). We have collected all publicly available POLG-related patient data and analyzed it using our pathogenic clustering model to provide a new research and clinical tool in the form of an online server. The server evaluates the pathogenicity of both previously reported and novel mutations. There are currently 176 unique point mutations reported and found in mitochondrial patients in the gene encoding the catalytic subunit of POLG, POLG. The mutations are distributed nearly uniformly along the length of the primary amino acid sequence of the gene. Our analysis shows that most of the mutations are recessive, and that the reported dominant mutations cluster within the polymerase active site in the tertiary structure of the POLG enzyme. The POLG Pathogenicity Prediction Server (http://polg.bmb.msu.edu) is targeted at clinicians and scientists studying POLG disorders, and aims to provide the most current available information regarding the pathogenicity of POLG mutations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland.
- Department of Biochemistry and Molecular Biology and Center for Mitochondrial Science and Medicine, Michigan State University, East Lansing, MI, USA.
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- University of Tampere
Zitieren
APA
Nurminen, A., Farnum, G. A., & Kaguni, L. S. (2017). Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database. BBA Clinical, 7, 147-156. https://doi.org/10.1016/j.bbacli.2017.04.001
Vancouver
Nurminen A, Farnum GA, Kaguni LS. Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database. BBA Clinical. 2017;7:147-156. doi:10.1016/j.bbacli.2017.04.001
BibTeX
@article{Nurminen2017,
author = {Nurminen, Anssi and Farnum, Gregory A and Kaguni, Laurie S},
title = {Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database},
journal = {BBA Clinical},
year = {2017},
volume = {7},
pages = {147--156},
doi = {10.1016/j.bbacli.2017.04.001}
}
EUVIMED